HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function.

Abstract
A case is described of chronic mucocutaneous candidiasis in association with thymoma. A plasma inhibitor of certain in vitro tests of cell mediated immune function, both of autologous and of normal cells was isolated from the patient's blood and shown to be stable on heating to 56 degrees C for 1 hour and to freezing and thawing. Isolation of the active fraction of Sephadex G-200 suggested a m.w. of 50,000-65,000 daltons. Despite disappearance of the inhibitor after apparently curative radiotherapy, suggesting the tumour was the origin, the chronic mucocutaneous candidiasis persists. The association of plasma inhibitors of immune function, with and without thymoma and chronic mucocutaneous candidiasis is reviewed and the possible nature of the substance discussed.
AuthorsP Gatenby, A Basten, E Adams
JournalJournal of clinical & laboratory immunology (J Clin Lab Immunol) Vol. 3 Issue 3 Pg. 209-16 (May 1980) ISSN: 0141-2760 [Print] Scotland
PMID7420408 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Autoantibodies
  • Immunoglobulins
  • Immunosuppressive Agents
  • Organic Chemicals
  • cell-mediated immune function inhibitor
Topics
  • Aged
  • Autoantibodies (analysis)
  • Candidiasis (immunology)
  • Candidiasis, Chronic Mucocutaneous (complications, immunology)
  • Female
  • Humans
  • Immune Tolerance
  • Immunity, Cellular
  • Immunoglobulins (analysis)
  • Immunosuppressive Agents (blood)
  • Lymphocyte Activation
  • Organic Chemicals
  • Thymoma (immunology)
  • Thymus Neoplasms (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: